Impact of Surgical Margins in Chest Wall Chondrosarcomas: A CanSaRCC Study
Journal of Surgical Oncology · 2026-07 · 134 (1) · 109-115
DOI: 10.1002/jso.70266 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Surgical Oncology, online erschienen am 23.04.2026. Verfasst von Aaron Gazendam und 21 weiteren Autor:innen. Beteiligte Einrichtung: Sinai Health System, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Bone Neoplasms, Chondrosarcoma, Margins of Excision, Thoracic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Chest wall chondrosarcoma is the most common primary malignant bone tumor of the thoracic cage. Owing to its resistance to chemotherapy and radiotherapy, complete surgical excision with negative margins remains the cornerstone of treatment. However, the optimal margin width for local control and survival remains uncertain.
Methods
Data from nine Canadian sarcoma centres participating in the CanSaRCC registry were retrospectively reviewed. Patients aged ≥ 18 years with pathologically confirmed primary chest wall chondrosarcoma (2000–2024) who underwent curative‐intent resection were included. Margins were defined as the minimum measured distance from tumor to resection margin, irrespective of tissue type and categorized as positive, < 4 mm, or ≥ 4 mm. Overall survival (OS), disease‐free survival (DFS), and local recurrence free survival (LRFS) were analysed using Kaplan–Meier and multivariable Cox regression.
Results
Among 147 patients (median age 54 years (range; 21–85), 16% had positive margins, 52% < 4 mm, and 24% ≥ 4 mm. At 5 years, OS and DFS were 77% (±4.8%) and 68% (±5.2%), respectively, for the entire cohort. Independent predictors of worse overall survival included tumor size ≥ 10 cm (HR 3.23, p = 0.021) and grade 3 tumors (HR 12.40, p < 0.001) but not margin size (margin ≥ 4 mm; HR 0.70, p = 0.512). Margins ≥ 4 mm significantly reduced local recurrence (HR 0.12, p = 0.023).
Conclusions
In primary chest wall chondrosarcoma, tumor biology rather than surgical margin width drives systemic outcomes. Margins ≥ 4 mm improve local control, supporting balanced resections that preserve function while maintaining oncologic safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sinai Health System, Toronto, Ontario, Canada.
- University Health Network, Toronto, Ontario, Canada.
- McGill University, Montreal, Quebec, Canada.
- Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
- BC Cancer, Vancouver, British Columbia, Canada.
- Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
ORCID-Profile: Evonne Henning, Ryan Trenholm, Luigi Russo, George Basile, Jamal Saade, Anthony Griffin, Peter Ferguson, Michael J Monument
Zitieren
APA
Gazendam, A., Peretz Soroka, H., Henning, E., Urrehman, B., Trenholm, R., Russo, L., Michael, M. J., Holloway, C., Grant, K., Basile, G., Saade, J., Cypel, M., Gupta, A., Griffin, A., Kubik, W., Ferguson, P., Arteau, A., Bozzo, A., Monument, M. J., …, & Wilson, D. (2026). Impact of Surgical Margins in Chest Wall Chondrosarcomas: A CanSaRCC Study. Journal of Surgical Oncology, 134(1), 109-115. https://doi.org/10.1002/jso.70266
Vancouver
Gazendam A, Peretz Soroka H, Henning E, Urrehman B, Trenholm R, Russo L, et al. Impact of Surgical Margins in Chest Wall Chondrosarcomas: A CanSaRCC Study. Journal of Surgical Oncology. 2026;134(1):109-115. doi:10.1002/jso.70266
BibTeX
@article{Gazendam2026,
author = {Gazendam, Aaron and Peretz Soroka, Hagit and Henning, Evonne and Urrehman, Burrak and Trenholm, Ryan and Russo, Luigi and Michael, Michelle Jude and Holloway, Caroline and Grant, Kyle and Basile, George and Saade, Jamal and Cypel, Marcelo and Gupta, Abha and Griffin, Anthony and Kubik, William and Ferguson, Peter and Arteau, Annie and Bozzo, Anthony and Monument, Michael J and Werier, Joel and Ednie, Alexander and Wilson, David},
title = {Impact of Surgical Margins in Chest Wall Chondrosarcomas: A CanSaRCC Study},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {134},
number = {1},
pages = {109--115},
doi = {10.1002/jso.70266}
}
EUVIMED